» Articles » PMID: 168604

Pharmacologic Interaction Between Cannabinol and Delta9-tetrahydrocannabinol

Overview
Specialty Pharmacology
Date 1975 Jan 1
PMID 168604
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The pharmacological activities of delta9-THC [(minus)-delta9-trans-tetrahydrocannabinol], CBN (Cannabinol) and mixtures of delta9-THC + CBN were studied in rabbits, rats and mice. CBN, although in general less active, mimicked the effects of delta9-THC in several pharmacological tests: corneal arreflexia in rabbits; climbing rope, open-field, irritability and aggressiveness after REM sleep deprivation in rats; catatonia, analgesia and sleeping time in mice. When the mixture delta9-THC + CBN was used, a synergistic effect occurred on most of the depressant effects. On the other hand CBN did not interfere with or slightly inhibited the excitatory effects of delta9-THC. In the one peripheral test used, CBN did not alter the delta9-THC effect.

Citing Articles

A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats.

Arnold J, Occelli Hanbury-Brown C, Anderson L, Bedoya-Perez M, Udoh M, Sharman L Neuropsychopharmacology. 2024; 50(3):586-595.

PMID: 39528623 PMC: 11736144. DOI: 10.1038/s41386-024-02018-7.


The Development of Cannabinoids as Therapeutic Agents in the United States.

Murray C, Gannon B, Winsauer P, Cooper Z, Delatte M Pharmacol Rev. 2024; 76(5):915-955.

PMID: 38849155 PMC: 11331953. DOI: 10.1124/pharmrev.123.001121.


Select Minor Cannabinoids from Are Cannabimimetic and Antinociceptive in a Mouse Model of Chronic Neuropathic Pain.

Schwarz A, Kobeci D, Mancuso J, Moreno-Rodriguez V, Seekins C, Bui T J Pharmacol Exp Ther. 2024; 391(2):214-221.

PMID: 38834356 PMC: 11493438. DOI: 10.1124/jpet.124.002212.


Cannabinol: History, Syntheses, and Biological Profile of the Greatest "Minor" Cannabinoid.

Maioli C, Mattoteia D, Amin H, Minassi A, Caprioglio D Plants (Basel). 2022; 11(21).

PMID: 36365350 PMC: 9658060. DOI: 10.3390/plants11212896.


Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research.

Caprioglio D, Amin H, Taglialatela-Scafati O, Munoz E, Appendino G Biomolecules. 2022; 12(8).

PMID: 36008978 PMC: 9406211. DOI: 10.3390/biom12081084.


References
1.
Willinsky M, Scotti de Carolis A, LONGO V . EEG and behavioral effects of natural, synthetic and biosynthetic cannabinoids. Psychopharmacologia. 1973; 31(4):365-74. DOI: 10.1007/BF00421280. View

2.
Borgen L, Lott G, Davis W . Cannabis-induced hypothermia: a dose-effect comparison of crude marihuana extract and synthetic 9 -tetrahydrocannabinol in male and female rats. Res Commun Chem Pathol Pharmacol. 1973; 5(3):621-6. View

3.
Grisham M, Ferraro D . Biphasic effects of 9 -tetrahydrocannabinol on variable interval schedule performance in rats. Psychopharmacologia. 1972; 27(2):163-9. DOI: 10.1007/BF00439375. View

4.
Hollister L . Marihuana in man: three years later. Science. 1971; 172(3978):21-9. DOI: 10.1126/science.172.3978.21. View

5.
Carlini E, Masur J . Development of aggressive behavior in rats by chronic administration of Cannabis sativa (marihuana). Life Sci. 1969; 8(11):607-20. DOI: 10.1016/0024-3205(69)90022-8. View